These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3044869)

  • 21. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):97-104. PubMed ID: 2861880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.
    Deering RB; Fox AS; Ison LJ
    J Int Med Res; 1977; 5(2):114-9. PubMed ID: 326593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind trial of captopril or bendrofluazide in newly diagnosed senile hypertension.
    Starr JM; Whalley LJ; Inch S; White A; Hadley L
    Curr Med Res Opin; 1994; 13(4):214-21. PubMed ID: 7882701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of a conventional dose, a low dose and alternate-day dosing of bendrofluazide in hypertensive patients.
    Girvin B; Johnston GD
    J Hypertens; 1998 Jul; 16(7):1049-54. PubMed ID: 9794747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of slow-release piretanide and bendroflumethiazide in the treatment of mild to moderate hypertension.
    Hegbrant J; Skogström K; Månsby J
    J Int Med Res; 1989; 17(5):426-34. PubMed ID: 2680677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension.
    Webster J; Dollery CT; Hensby CN
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():125s-128s. PubMed ID: 7004720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose antihypertensive treatment with a thiazide diuretic is not diabetogenic. A 10-year controlled trial with bendroflumethiazide.
    Berglund G; Andersson O; Widgren B
    Acta Med Scand; 1986; 220(5):419-24. PubMed ID: 3544690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide.
    Polak G; Reid JL; Hamilton CA; Jones DH; Dollery CT
    Clin Exp Hypertens (1978); 1978; 1(1):1-9. PubMed ID: 755641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labetalol and bendrofluazide: comparison of their antihypertensive effects.
    Horvath JS; Caterson RJ; Collett P; Duggin GG; Kelly DH; Tiller DJ
    Med J Aust; 1979 Jun; 1(13):626-8. PubMed ID: 386062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further results of the MRC treatment trial for mild hypertension.
    Miall WE; Greenberg G; Brennan P
    Nephron; 1987; 47 Suppl 1():111-4. PubMed ID: 3320784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The systemic haemodynamic and cerebral autoregulatory effects of bendrofluazide in the subacute post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    J Hypertens; 2004 Oct; 22(10):2017-24. PubMed ID: 15361775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the acute effects of cicletanine and bendrofluazide on urinary electrolytes and plasma potassium in essential hypertension.
    Singer DR; Markandu ND; Sugden AL; MacGregor GA
    Eur J Clin Pharmacol; 1990; 39(3):227-32. PubMed ID: 2257857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect and side-effects of bendroflumethiazide and propranolol.
    Berglund G; Andersson O; Larsson O; Wilhelmsen L
    Acta Med Scand; 1976; 199(6):499-506. PubMed ID: 937076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension].
    Wheatley D
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3278-81. PubMed ID: 768909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on the Medical Research Council Hypertension Trial.
    Dollery CT
    J Hypertens Suppl; 1987 Aug; 5(3):S75-8. PubMed ID: 3312530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary heart disease in the Medical Research Council trial of treatment of mild hypertension. Medical Research Council Working Party on Mild Hypertension.
    Br Heart J; 1988 Mar; 59(3):364-78. PubMed ID: 2895662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.
    Roberts CJ; Marshall AJ; Heaton S; Barritt DW
    Br Med J; 1979 Jan; 1(6158):224-6. PubMed ID: 369652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.